Could 'Good Bacteria' capsules beat BV without antibiotics?
NCT ID NCT07418996
First seen Feb 20, 2026 · Last updated Jun 24, 2026 · Updated 15 times
Summary
This study tested whether vaginal capsules containing live lactobacilli (good bacteria) are safe and tolerable for treating bacterial vaginosis (BV), a common vaginal infection. Fifty-seven women with BV received either the lactobacillus capsules or the standard antibiotic metronidazole. The main goal was to check for side effects, with secondary goals looking at cure and recurrence rates.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL VAGINOSIS (BV) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Guangdong Longchuangji Pharmaceutical Co., Ltd.
Chaozhou, Guangdong, 521000, China
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
live lactobacillus vaginal capsules
What this could lead to
If successful, this could offer a new, gentler treatment option for bacterial vaginosis that uses good bacteria instead of antibiotics.
What could go wrong
This is an early Phase 2a trial with only 57 participants, so results may not apply to everyone. The treatment may not work better than existing options or could cause side effects.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.